The global liquid biopsy market by Products & Services (Reagents & Kits, Equipment, and Services), By Sample (Cell Free DNA, Circulating Tumor Cells, and Exosomes), By Application (Oncology Testing, Non-Invasive Prenatal Testing, and Transplant Care), By End User (Hospitals, Research Laboratories, Diagnostic Laboratories, and Patients), and Region (North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa) nwas valued at US$ 1,824.7 million in 2016 and is projected to exhibit a CAGR of 18.3% over the forecast period (2017–2025), as highlighted in a new report published by Coherent Market Insights. Advantages offered by liquid biopsy over conventional tissue biopsies such as early detection, and avoidance of biases in results due to cancer heterogeneity, rising prevalence of cancer, and increasing awareness and demand for minimally invasive procedures is expected to fuel growth of the liquid biopsy market.
Get The Holistic SAMPLE With Research Methodology:
https://www.coherentmarketinsights.com/insight/request-sample/1223
Key Takeaways of the Liquid Biopsy Market:
The global liquid biopsy market is expected to exhibit a CAGR of 3% over the forecast period (2017–2025), owing to increasing research and development in the liquid biopsy studies and associated product launches by the key players such as Guardant Health
Strong competition in the market has led to increasing focus on continuous development, as manufacturers strive to stay competitive in the market. This is expected to aid in market growth over the forecast period.
Increasing application and effectiveness of liquid biopsy in diagnosis of various cancers such as colorectal cancer, breast cancer, and diseases such as coronary heart disease is expected to boost growth of the liquid biopsy market over the forecast period
North America region is expected to witness significant growth owing to presence of players such as Biocept and presence of research oriented players such as Guardant Health, Inc.
Major players operating in the liquid biopsy market include Illumina, Inc., Roche AG, Natera, Inc., Laboratory Corporation of America Holdings (LabCorp), Qiagen N.V., Thermo Fisher Scientific Inc., Exact Sciences Corp., Biocept, Inc., Genomic Health, Inc., Guardant Health, TrovaGene Inc., CareDx Inc., Adaptive Biotechnologies Corporation, and Biocartis SA.
Ask For Customisation:
https://www.coherentmarketinsights.com/insight/request-customization/1223
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Contact Us:
Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email:[email protected]
Visit our news Website: https://www.coherenttimes.org
Hi! I am a robot. I just upvoted you! I found similar content that readers might be interested in:
http://reports.pr-inside.com/liquid-biopsy-market-global-trend-and-growth-in-ne-r4694719.htm
Downvoting a post can decrease pending rewards and make it less visible. Common reasons:
Submit